The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
2020 · Nature Immunology · 785 citations
https://doi.org/10.1038/s41590-020-0769-3
K
Kota Itahashi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
2.3K
Citations
12
h-index
12
i10-index
Kota Itahashi is an academic researcher from National Cancer Center Hospital East. The author has contributed to research in topics: Heat shock proteins research & Hormonal Regulation and Hypertension & Cancer Immunotherapy and Biomarkers. The author has an h-index of 12, co-authored 48 publications.
ORCID: 0000-0002-1676-8466Papers by this author
worksLactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
2022 · Cancer Cell · 778 citations
https://doi.org/10.1016/j.ccell.2022.01.001
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors
2022 · Science Immunology · 98 citations
https://doi.org/10.1126/sciimmunol.abk0957
Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab
2021 · Nature Communications · 50 citations
https://doi.org/10.1038/s41467-021-27574-0
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma – a multicenter phase 2 trial (EPOC1802)
2025 · Nature Cancer · 6 citations
https://doi.org/10.1038/s43018-025-00918-1
Table S3 from The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment
2025 · 0 citations
https://doi.org/10.1158/2326-6066.28332887
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat